Naoyuki Matsuda Selected Research

Glucose (Dextrose)

10/2021	Impact of a long-term high-glucose environment on pro-inflammatory responses in macrophages stimulated with lipopolysaccharide.
10/2009	Nuclear factor-kappaB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoyuki Matsuda Research Topics

Disease

41	Sepsis (Septicemia) 01/2024 - 08/2002
16	Septic Shock (Toxic Shock Syndrome) 01/2024 - 08/2002
14	Inflammation (Inflammations) 01/2024 - 12/2002
7	Acute Lung Injury 12/2020 - 11/2004
6	Tachycardia (Tachyarrhythmias) 11/2020 - 12/2002
6	Multiple Organ Failure (MODS) 01/2016 - 08/2002
5	Post-Cardiac Arrest Syndrome 11/2021 - 05/2017
4	Heart Arrest (Cardiac Arrest) 01/2021 - 12/2016
4	Shock 01/2019 - 10/2003
4	Endotoxemia 08/2006 - 12/2002
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2005 - 08/2002
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2020
3	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 05/2020
3	Hypotension (Low Blood Pressure) 01/2020 - 12/2002
3	Heart Failure 08/2018 - 01/2003
3	Critical Illness (Critically Ill) 01/2018 - 10/2003
3	Lung Injury 12/2016 - 03/2008
3	Disseminated Intravascular Coagulation 01/2005 - 01/2003
2	Pulmonary Edema 01/2022 - 01/2021
2	Neoplasms (Cancer) 10/2021 - 01/2019
2	Necrosis 10/2021 - 01/2019
2	Delirium 02/2020 - 01/2018
2	Low Cardiac Output 01/2018 - 06/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2018 - 01/2003
2	Pancreatitis 01/2017 - 08/2006
2	Infections 12/2016 - 02/2016
2	Hyperglycemia 10/2009 - 02/2008
1	Bacterial Infections (Bacterial Infection) 01/2024
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Obesity 10/2021
1	Lymphoma (Lymphomas) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Pulmonary Embolism 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Out-of-Hospital Cardiac Arrest 01/2021
1	Edema (Dropsy) 12/2020
1	COVID-19 12/2020
1	Pneumonia (Pneumonitis) 12/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2020
1	Sinus Tachycardia 01/2020
1	Atrial Flutter (Flutter, Atrial) 01/2020

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2024 - 01/2014
7	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 12/2002
7	NF-kappa B (NF-kB)IBA 01/2019 - 12/2004
6	OligodeoxyribonucleotidesIBA 01/2020 - 12/2004
5	Dacarbazine (DIC)FDA LinkGeneric 01/2005 - 08/2002
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2005
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2018 - 03/2008
4	LipopolysaccharidesIBA 11/2012 - 12/2002
4	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2005 - 08/2002
3	Oxygen (Dioxygen)IBA 01/2021 - 05/2020
3	landiololIBA 11/2020 - 01/2014
3	NF-kappaB decoyIBA 03/2010 - 12/2004
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2008
2	Nucleic AcidsIBA 01/2022 - 08/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2020
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2018
2	Insulin (Novolin)FDA Link 10/2021 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 10/2009
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2020 - 01/2019
2	CatecholaminesIBA 02/2020 - 01/2020
2	MelatoninIBA 02/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 02/2015
2	Dobutamine FDA LinkGeneric 01/2018 - 06/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 12/2008
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018 - 04/2005
2	Simendan (Levosimendan)IBA 01/2018 - 11/2015
2	Milrinone (Primacor)FDA LinkGeneric 01/2018 - 06/2017
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2011 - 12/2008
2	Peptide Hydrolases (Proteases)FDA Link 01/2010 - 08/2006
2	Caspase 3 (Caspase-3)IBA 01/2010 - 10/2007
2	Proteinase-Activated ReceptorsIBA 08/2006 - 11/2004
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	SelectinsIBA 01/2005 - 12/2002
2	ThrombomodulinIBA 01/2005 - 12/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2005 - 12/2002
2	EndotoxinsIBA 11/2004 - 10/2003
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2003 - 08/2002
2	Thromboplastin (Tissue Factor)IBA 01/2003 - 08/2002
1	ExotoxinsIBA 01/2024
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2024
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	InterleukinsIBA 10/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Bevacizumab (Avastin)FDA Link 12/2020
1	Monoclonal AntibodiesIBA 12/2020

Therapy/Procedure

17	Punctures 12/2020 - 04/2005
17	Ligation 12/2020 - 01/2003
15	Therapeutics 01/2024 - 12/2006
7	Induced Hypothermia 11/2021 - 12/2016
7	Critical Care (Surgical Intensive Care) 08/2021 - 01/2014
3	Extracorporeal Membrane Oxygenation 01/2021 - 08/2018
2	Resuscitation 01/2020 - 08/2011
2	Intravenous Injections 01/2019 - 12/2004
2	Anesthesia 10/2012 - 08/2012
2	Hemodiafiltration 11/2003 - 10/2003
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Cannula 05/2020